Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.06 trillion and total revenue of $110.19 billion.
Market Cap
1.06T
Revenue
110.19B
Profits
-42.02B
PE Ratio
n/a
Profit Margin
-38.13%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.96B | -0.34% | 604,524 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.89B | -0.09% | 248,162 | 14.34B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.16B | 2.17% | 725,557 | 3.71B |
| 4 | ARGX | argenx SE | 41.68B | -1.61% | 146,206 | 4.24B |
| 5 | ONC | BeOne Medicines AG | 31.04B | -0.95% | 60,946 | 5.34B |
| 6 | INSM | Insmed Incorporated | 30.17B | -2.80% | 550,061 | 606.42M |
| 7 | BNTX | BioNTech SE | 22.12B | -1.47% | 224,110 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 20.47B | -1.03% | 2,254,325 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.70B | -0.97% | 1,681,329 | 13.31M |
| 10 | RPRX | Royalty Pharma plc | 19.39B | -0.61% | 915,055 | 2.38B |
| 11 | RVMD | Revolution Medicines, Inc. | 19.08B | -3.06% | 609,954 | - |
| 12 | INCY | Incyte Corporation | 18.19B | -1.69% | 870,330 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.59B | -2.10% | 1,325,246 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.84B | 0.72% | 117,779 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.32B | -1.97% | 871,697 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.44B | 2.10% | 1,018,623 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.76B | -0.17% | 826,879 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.20B | 0.04% | 216,950 | 4.27B |
| 19 | EXEL | Exelixis, Inc. | 10.75B | 0.29% | 939,133 | 2.32B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.49B | -0.89% | 735,958 | 3.22B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.32B | -0.93% | 123,491 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 9.77B | 2.04% | 661,283 | 6.23M |
| 23 | IBRX | ImmunityBio, Inc. | 8.90B | -1.81% | 16,153,251 | 113.29M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.41B | 1.55% | 177,142 | 7.46M |
| 25 | TECH | Bio-Techne Corporation | 8.09B | 0.17% | 726,014 | 1.22B |
| 26 | AXSM | Axsome Therapeutics, Inc. | 7.99B | -1.65% | 225,942 | 638.50M |
| 27 | PCVX | Vaxcyte, Inc. | 7.94B | 2.22% | 681,019 | - |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.83B | -1.81% | 681,384 | 1.09B |
| 29 | CYTK | Cytokinetics, Incorporated | 7.67B | -1.10% | 697,571 | 88.04M |
| 30 | NUVL | Nuvalent, Inc. | 7.58B | -0.70% | 150,044 | - |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.48B | 0.24% | 527,030 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 7.41B | -1.80% | 182,783 | 389.13M |
| 33 | ACLX | Arcellx, Inc. | 6.69B | 0.07% | 753,369 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.52B | 0.29% | 267,588 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.37B | -1.76% | 437,914 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.21B | -0.92% | 61,260 | - |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.10B | -1.05% | 1,906,657 | 189.76M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.51B | -1.85% | 567,883 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 5.49B | -1.14% | 294,762 | 1.73B |
| 40 | CGON | CG Oncology, Inc. | 5.46B | -1.73% | 584,676 | 4.04M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.30B | -3.15% | 454,146 | 521.31M |
| 42 | CAI | Caris Life Sciences, Inc. | 5.29B | -0.43% | 707,848 | 812.03M |
| 43 | XENE | Xenon Pharmaceuticals Inc. | 5.26B | -0.04% | 318,877 | 7.50M |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.26B | 0.62% | 1,338,333 | - |
| 45 | CELC | Celcuity Inc. | 4.98B | -4.80% | 346,938 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 4.82B | -0.49% | 917,960 | 616.29M |
| 47 | IMVT | Immunovant, Inc. | 4.81B | -0.08% | 355,268 | - |
| 48 | ERAS | Erasca, Inc. | 4.75B | 0.07% | 1,986,149 | - |
| 49 | APGE | Apogee Therapeutics, Inc. | 4.59B | -3.55% | 316,751 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.52B | 0.07% | 1,542,548 | 634.21M |
| 51 | CRSP | CRISPR Therapeutics AG | 4.49B | -0.28% | 807,182 | 3.51M |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.39B | -0.71% | 973,023 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.19B | -0.20% | 188,632 | 268.09M |
| 54 | VKTX | Viking Therapeutics, Inc. | 3.90B | -0.38% | 719,098 | - |
| 55 | CORT | Corcept Therapeutics Incorporated | 3.79B | 4.46% | 778,562 | 761.41M |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.75B | -0.06% | 351,702 | 7.70M |
| 57 | CNTA | Centessa Pharmaceuticals plc | 3.72B | -2.40% | 138,495 | 15.00M |
| 58 | ACAD | ACADIA Pharmaceuticals Inc. | 3.55B | 0.39% | 595,074 | 1.07B |
| 59 | ADMA | ADMA Biologics, Inc. | 3.50B | -2.06% | 1,530,907 | 510.17M |
| 60 | GPCR | Structure Therapeutics Inc. | 3.50B | -2.01% | 333,425 | - |
| 61 | DNTH | Dianthus Therapeutics, Inc. | 3.45B | -3.03% | 192,237 | 2.04M |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.43B | -2.07% | 357,498 | 22.50M |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.35B | 0.90% | 246,992 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.30B | -0.06% | 439,719 | 1.03B |
| 65 | DNLI | Denali Therapeutics Inc. | 3.21B | 2.48% | 678,847 | - |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.20B | -0.60% | 258,387 | - |
| 67 | ALMS | Alumis Inc. | 3.14B | -2.68% | 492,503 | 24.05M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.00B | 3.27% | 100,234 | 803.79M |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.99B | 1.91% | 1,290,397 | - |
| 70 | VERA | Vera Therapeutics, Inc. | 2.94B | -0.36% | 401,593 | - |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.90B | 1.26% | 364,780 | 218.71M |
| 72 | ARQT | Arcutis Biotherapeutics, Inc. | 2.87B | 1.00% | 785,661 | 376.07M |
| 73 | TARS | Tarsus Pharmaceuticals, Inc. | 2.83B | -0.54% | 127,557 | 451.36M |
| 74 | VRDN | Viridian Therapeutics, Inc. | 2.82B | -0.97% | 491,132 | 70.85M |
| 75 | RCUS | Arcus Biosciences, Inc. | 2.80B | -0.31% | 320,776 | 247.00M |
| 76 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.77B | 1.61% | 388,878 | 588.99M |
| 77 | TNGX | Tango Therapeutics, Inc. | 2.73B | -1.14% | 929,421 | 62.38M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.61B | 1.99% | 697,903 | 139.74M |
| 79 | TVTX | Travere Therapeutics, Inc. | 2.48B | -2.81% | 553,656 | 490.73M |
| 80 | MAZE | Maze Therapeutics, Inc. | 2.41B | 1.44% | 210,932 | 2.50M |
| 81 | IMNM | Immunome, Inc. | 2.36B | 0.10% | 595,939 | 6.94M |
| 82 | APLS | Apellis Pharmaceuticals, Inc. | 2.29B | -0.33% | 478,895 | 1.00B |
| 83 | WVE | Wave Life Sciences Ltd. | 2.27B | -0.41% | 694,069 | 42.73M |
| 84 | IRON | Disc Medicine, Inc. | 2.27B | 0.42% | 225,419 | - |
| 85 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.07% | 724,506 | 158.18M |
| 86 | MANE | Veradermics, Incorporated | 2.20B | 3.44% | 161,231 | - |
| 87 | SNDX | Syndax Pharmaceuticals, Inc. | 2.20B | 3.83% | 1,177,054 | 172.35M |
| 88 | NKTR | Nektar Therapeutics | 2.13B | -0.96% | 225,496 | 55.23M |
| 89 | GLPG | Galapagos NV | 2.11B | -1.71% | 53,876 | 1.31B |
| 90 | TYRA | Tyra Biosciences, Inc. | 2.08B | 1.36% | 256,184 | - |
| 91 | ADPT | Adaptive Biotechnologies Corporation | 2.07B | -0.52% | 516,826 | 276.98M |
| 92 | CLDX | Celldex Therapeutics, Inc. | 2.06B | 2.83% | 484,012 | 1.55M |
| 93 | STOK | Stoke Therapeutics, Inc. | 2.02B | 3.10% | 372,789 | 184.42M |
| 94 | ZLAB | Zai Lab Limited | 1.99B | -3.25% | 616,822 | 460.16M |
| 95 | MLYS | Mineralys Therapeutics, Inc. | 1.99B | 3.48% | 958,468 | - |
| 96 | AAPG | Ascentage Pharma Group International | 1.97B | -4.08% | 1,911 | 54.52M |
| 97 | RARE | Ultragenyx Pharmaceutical Inc. | 1.96B | -0.56% | 644,918 | 673.00M |
| 98 | ORKA | Oruka Therapeutics, Inc. | 1.94B | 0.67% | 359,136 | - |
| 99 | DFTX | Definium Therapeutics, Inc. | 1.89B | 1.77% | 799,591 | - |
| 100 | MESO | Mesoblast Limited | 1.88B | -1.29% | 105,079 | 65.38M |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 1.86B | -0.71% | 290,889 | 283.06M |
| 102 | RLAY | Relay Therapeutics, Inc. | 1.84B | 3.05% | 1,234,340 | 15.36M |
| 103 | OCUL | Ocular Therapeutix, Inc. | 1.83B | 1.45% | 1,107,003 | 51.95M |
| 104 | ANAB | AnaptysBio, Inc. | 1.82B | -2.44% | 663,478 | 234.60M |
| 105 | SRPT | Sarepta Therapeutics, Inc. | 1.81B | 3.72% | 930,900 | 2.20B |
| 106 | ELVN | Enliven Therapeutics, Inc. | 1.79B | -0.17% | 285,772 | - |
| 107 | CAPR | Capricor Therapeutics, Inc. | 1.79B | -0.16% | 410,998 | 11.13M |
| 108 | RXRX | Recursion Pharmaceuticals, Inc. | 1.77B | -0.45% | 4,986,682 | 74.68M |
| 109 | ZYME | Zymeworks Inc. | 1.74B | -1.15% | 187,594 | 105.97M |
| 110 | SLNO | Soleno Therapeutics, Inc. | 1.72B | -0.71% | 413,585 | 190.41M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.65B | 0.93% | 194,415 | 54.03M |
| 112 | VCEL | Vericel Corporation | 1.63B | -2.05% | 232,568 | 276.26M |
| 113 | SION | Sionna Therapeutics, Inc. | 1.63B | 1.83% | 90,170 | - |
| 114 | INVA | Innoviva, Inc. | 1.61B | -1.81% | 304,636 | 411.33M |
| 115 | NVAX | Novavax, Inc. | 1.61B | 1.23% | 1,704,428 | 1.12B |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.32% | 198,574 | 868.45M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 1.58B | 1.83% | 1,671,822 | 67.67M |
| 118 | NRIX | Nurix Therapeutics, Inc. | 1.56B | 1.68% | 631,924 | 83.98M |
| 119 | GENB | Generate Biomedicines, Inc. | 1.56B | -0.41% | 209,736 | 31.89M |
| 120 | IOVA | Iovance Biotherapeutics, Inc. | 1.55B | -2.71% | 5,748,563 | 263.50M |
| 121 | IMCR | Immunocore Holdings plc | 1.52B | -0.20% | 84,099 | 400.02M |
| 122 | NUVB | Nuvation Bio Inc. | 1.50B | 1.41% | 2,098,600 | 62.90M |
| 123 | OCS | Oculis Holding AG | 1.48B | -1.46% | 152,970 | 1.51M |
| 124 | NBTX | Nanobiotix S.A. | 1.45B | -5.09% | 29,113 | 11.93M |
| 125 | PHVS | Pharvaris N.V. | 1.44B | 0.57% | 29,524 | - |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.39B | 1.31% | 653,933 | - |
| 127 | BHVN | Biohaven Ltd. | 1.39B | 2.90% | 729,868 | - |
| 128 | PVLA | Palvella Therapeutics, Inc. | 1.35B | 0.12% | 69,379 | - |
| 129 | MBX | MBX Biosciences, Inc. | 1.34B | -0.88% | 132,695 | - |
| 130 | ARDX | Ardelyx, Inc. | 1.34B | -1.00% | 1,453,417 | 407.32M |
| 131 | RAPP | Rapport Therapeutics, Inc. | 1.32B | 0.87% | 80,176 | - |
| 132 | ZBIO | Zenas BioPharma, Inc. | 1.31B | -2.16% | 149,911 | 10.00M |
| 133 | ATAI | AtaiBeckley Inc. | 1.31B | 0.84% | 1,169,208 | 4.09M |
| 134 | VIR | Vir Biotechnology, Inc. | 1.29B | -1.76% | 802,674 | 68.56M |
| 135 | GLUE | Monte Rosa Therapeutics, Inc. | 1.29B | - | 470,884 | 123.67M |
| 136 | IMTX | Immatics N.V. | 1.28B | -1.96% | 87,605 | 56.67M |
| 137 | OLMA | Olema Pharmaceuticals, Inc. | 1.28B | -2.14% | 541,351 | - |
| 138 | TSHA | Taysha Gene Therapies, Inc. | 1.27B | -2.74% | 1,039,707 | 9.77M |
| 139 | KOD | Kodiak Sciences Inc. | 1.22B | 1.70% | 233,939 | - |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.18B | -1.02% | 156,133 | - |
| 141 | PGEN | Precigen, Inc. | 1.17B | -0.30% | 1,150,469 | 6.31M |
| 142 | CRVS | Corvus Pharmaceuticals, Inc. | 1.16B | -1.63% | 439,215 | - |
| 143 | DMRA | Damora Therapeutics, Inc. | 1.15B | -0.42% | 318,133 | - |
| 144 | EYPT | EyePoint, Inc. | 1.15B | -0.36% | 292,885 | 31.37M |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.12B | 0.18% | 578,158 | - |
| 146 | SEPN | Septerna, Inc. | 1.08B | -0.91% | 73,093 | 45.95M |
| 147 | ABCL | AbCellera Biologics Inc. | 1.07B | -0.42% | 862,879 | 75.13M |
| 148 | PHAR | Pharming Group N.V. | 1.06B | 0.16% | 14,883 | 376.13M |
| 149 | QURE | uniQure N.V. | 1.04B | 9.04% | 1,718,078 | 16.10M |
| 150 | TVGN | Tevogen Bio Holdings Inc. | 1.03B | -3.95% | 22,111 | - |
| 151 | SVRA | Savara Inc. | 1.02B | -3.10% | 1,045,661 | - |
| 152 | BCAX | Bicara Therapeutics Inc. | 1.02B | -0.64% | 141,395 | - |
| 153 | AVBP | ArriVent BioPharma, Inc. | 1.00B | -0.70% | 94,899 | - |
| 154 | GERN | Geron Corporation | 973.63M | -1.94% | 14,634,869 | 183.88M |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 955.27M | -0.72% | 442,803 | 291.85M |
| 156 | SLS | SELLAS Life Sciences Group, Inc. | 951.79M | 1.92% | 4,917,041 | - |
| 157 | CMPX | Compass Therapeutics, Inc. | 943.66M | -2.78% | 602,329 | 850.00K |
| 158 | VALN | Valneva SE | 921.50M | 1.26% | 835 | 205.07M |
| 159 | INBX | Inhibrx Biosciences, Inc. | 910.16M | -3.95% | 84,827 | 1.30M |
| 160 | XNCR | Xencor, Inc. | 896.20M | 0.83% | 839,691 | 125.58M |
| 161 | GHRS | GH Research PLC | 894.15M | -2.67% | 66,383 | - |
| 162 | PHAT | Phathom Pharmaceuticals, Inc. | 893.58M | 1.70% | 757,445 | 175.11M |
| 163 | AKTS | Aktis Oncology, Inc. | 892.88M | -5.45% | 191,561 | 5.56M |
| 164 | FTRE | Fortrea Holdings Inc. | 890.12M | -2.76% | 501,214 | 2.72B |
| 165 | URGN | UroGen Pharma Ltd. | 874.82M | -3.34% | 169,650 | 109.79M |
| 166 | JANX | Janux Therapeutics, Inc. | 863.20M | 0.21% | 414,023 | 10.00M |
| 167 | KALV | KalVista Pharmaceuticals, Inc. | 862.32M | 3.83% | 396,563 | 1.43M |
| 168 | SGP | SpyGlass Pharma, Inc. | 856.26M | -0.04% | 37,338 | - |
| 169 | SANA | Sana Biotechnology, Inc. | 848.64M | 0.32% | 1,252,440 | - |
| 170 | EVMN | Evommune, Inc. | 833.10M | -1.83% | 91,378 | 13.00M |
| 171 | SPRY | ARS Pharmaceuticals, Inc. | 831.12M | 1.45% | 368,647 | 84.28M |
| 172 | ABUS | Arbutus Biopharma Corporation | 826.99M | -1.60% | 636,303 | 14.61M |
| 173 | IVA | Inventiva S.A. | 811.25M | -3.48% | 191,145 | 19.93M |
| 174 | CGEM | Cullinan Therapeutics, Inc. | 792.89M | 0.15% | 244,716 | - |
| 175 | OMER | Omeros Corporation | 791.96M | 0.45% | 258,430 | - |
| 176 | ANL | Adlai Nortye Ltd. | 781.55M | -4.08% | 85,853 | -1.35M |
| 177 | MPLT | MapLight Therapeutics, Inc. | 775.60M | 1.61% | 99,536 | - |
| 178 | CTMX | CytomX Therapeutics, Inc. | 767.54M | -5.65% | 3,237,768 | 76.20M |
| 179 | MNKD | MannKind Corporation | 765.63M | -1.39% | 2,685,255 | 348.97M |
| 180 | KURA | Kura Oncology, Inc. | 742.85M | -0.24% | 473,366 | 67.48M |
| 181 | DRUG | Bright Minds Biosciences Inc. | 714.81M | 0.80% | 33,383 | - |
| 182 | SLDB | Solid Biosciences Inc. | 712.35M | 1.69% | 606,001 | - |
| 183 | TBPH | Theravance Biopharma, Inc. | 709.92M | - | 165,413 | 107.46M |
| 184 | ARVN | Arvinas, Inc. | 708.69M | -0.81% | 246,953 | 262.60M |
| 185 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 708.29M | -2.21% | 35,430 | - |
| 186 | OCGN | Ocugen, Inc. | 701.70M | -4.46% | 4,136,622 | 4.41M |
| 187 | JBIO | Jade Biosciences, Inc. | 685.00M | -1.35% | 117,642 | - |
| 188 | ANRO | Alto Neuroscience, Inc. | 684.27M | -2.81% | 131,377 | - |
| 189 | PRME | Prime Medicine, Inc. | 662.63M | -0.27% | 912,802 | 4.63M |
| 190 | LXRX | Lexicon Pharmaceuticals, Inc. | 656.70M | -4.32% | 1,900,130 | 49.80M |
| 191 | GYRE | Gyre Therapeutics, Inc. | 655.47M | -0.59% | 66,369 | 116.59M |
| 192 | RLMD | Relmada Therapeutics, Inc. | 644.55M | -1.68% | 432,512 | - |
| 193 | DSGN | Design Therapeutics, Inc. | 641.39M | 1.36% | 58,629 | - |
| 194 | ANNX | Annexon, Inc. | 638.84M | -2.73% | 750,702 | - |
| 195 | EIKN | Eikon Therapeutics, Inc. | 632.97M | 6.79% | 87,320 | - |
| 196 | DRTS | Alpha Tau Medical Ltd. | 627.07M | -2.66% | 78,015 | - |
| 197 | MDXG | MiMedx Group, Inc. | 615.81M | -0.60% | 386,624 | 418.63M |
| 198 | LBRX | LB Pharmaceuticals Inc | 609.96M | 0.50% | 61,240 | - |
| 199 | AGMB | AgomAb Therapeutics NV | 603.85M | -2.44% | 65,859 | - |
| 200 | MGTX | MeiraGTx Holdings plc | 589.19M | -0.41% | 120,623 | 27.42M |
| 201 | REPL | Replimune Group, Inc. | 581.31M | 2.18% | 889,850 | - |
| 202 | TECX | Tectonic Therapeutic, Inc. | 575.79M | -0.54% | 61,148 | - |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 551.30M | -0.11% | 176,370 | 106.47M |
| 204 | ZURA | Zura Bio Limited | 539.87M | -7.03% | 422,504 | - |
| 205 | ALLO | Allogene Therapeutics, Inc. | 536.31M | -0.90% | 1,676,267 | 22.00K |
| 206 | DBVT | DBV Technologies S.A. | 531.30M | -0.21% | 182,138 | 5.50M |
| 207 | VSTM | Verastem, Inc. | 510.32M | -0.17% | 587,073 | 30.91M |
| 208 | LRMR | Larimar Therapeutics, Inc. | 510.07M | 9.84% | 1,208,008 | - |
| 209 | ADCT | ADC Therapeutics SA | 503.10M | -1.98% | 233,793 | 81.36M |
| 210 | CRMD | CorMedix Inc. | 499.60M | 0.32% | 423,218 | 311.71M |
| 211 | ENGN | enGene Holdings Inc. | 493.38M | 2.08% | 69,386 | - |
| 212 | RIGL | Rigel Pharmaceuticals, Inc. | 482.15M | - | 93,960 | 294.28M |
| 213 | RCKT | Rocket Pharmaceuticals, Inc. | 476.62M | - | 1,166,099 | - |
| 214 | CTNM | Contineum Therapeutics, Inc. | 473.79M | 4.79% | 813,993 | - |
| 215 | AVIR | Atea Pharmaceuticals, Inc. | 471.66M | -1.33% | 260,896 | - |
| 216 | EPRX | Eupraxia Pharmaceuticals Inc. | 470.90M | -5.39% | 81,641 | - |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 470.20M | 0.28% | 273,663 | 80.00M |
| 218 | PRTA | Prothena Corporation plc | 469.42M | 2.11% | 200,209 | 9.68M |
| 219 | LYEL | Lyell Immunopharma, Inc. | 467.31M | -3.47% | 42,352 | 36.00K |
| 220 | IPSC | Century Therapeutics, Inc. | 463.68M | 3.61% | 627,183 | 109.16M |
| 221 | UPB | Upstream Bio, Inc. | 458.52M | 1.25% | 324,597 | 2.80M |
| 222 | ABSI | Absci Corporation | 456.38M | -1.46% | 1,911,692 | 2.82M |
| 223 | FDMT | 4D Molecular Therapeutics, Inc. | 454.87M | -0.78% | 290,198 | 85.21M |
| 224 | VNDA | Vanda Pharmaceuticals Inc. | 453.95M | -10.39% | 3,360,946 | 216.11M |
| 225 | ASMB | Assembly Biosciences, Inc. | 452.88M | 3.78% | 31,340 | 72.30M |
| 226 | ALT | Altimmune, Inc. | 450.04M | 1.17% | 1,421,697 | 41.00K |
| 227 | MRVI | Maravai LifeSciences Holdings, Inc. | 443.54M | - | 1,814,849 | 185.74M |
| 228 | STTK | Shattuck Labs, Inc. | 442.27M | 1.31% | 298,993 | 1.00M |
| 229 | ACRS | Aclaris Therapeutics, Inc. | 437.76M | -2.94% | 440,108 | 7.83M |
| 230 | TRDA | Entrada Therapeutics, Inc. | 437.21M | -4.67% | 144,095 | 25.42M |
| 231 | RGNX | REGENXBIO Inc. | 432.00M | 0.12% | 333,206 | 170.44M |
| 232 | NMRA | Neumora Therapeutics, Inc. | 427.75M | -0.39% | 191,158 | - |
| 233 | AURA | Aura Biosciences, Inc. | 421.03M | 0.76% | 97,088 | - |
| 234 | LXEO | Lexeo Therapeutics, Inc. | 414.57M | -1.90% | 368,435 | - |
| 235 | XFOR | X4 Pharmaceuticals, Inc. | 409.14M | 7.91% | 264,097 | 35.11M |
| 236 | DNA | Ginkgo Bioworks Holdings, Inc. | 405.40M | -0.43% | 435,698 | 170.16M |
| 237 | IVVD | Invivyd, Inc. | 402.70M | -1.72% | 673,766 | 53.43M |
| 238 | BNTC | Benitec Biopharma Inc. | 392.67M | -0.61% | 45,761 | - |
| 239 | AVXL | Anavex Life Sciences Corp. | 388.29M | -0.24% | 463,284 | - |
| 240 | AUTL | Autolus Therapeutics plc | 383.25M | 0.70% | 574,717 | 51.13M |
| 241 | MNPR | Monopar Therapeutics Inc. | 382.51M | -2.44% | 126,856 | - |
| 242 | NAGE | Niagen Bioscience, Inc. | 381.98M | 0.63% | 387,886 | 129.42M |
| 243 | PRTC | PureTech Health plc | 381.76M | -2.22% | 1,229 | 6.39M |
| 244 | YDES | YD Bio Limited | 381.13M | - | 50,753 | 510.36K |
| 245 | NAUT | Nautilus Biotechnology, Inc. | 375.13M | 8.00% | 279,431 | - |
| 246 | LCTX | Lineage Cell Therapeutics, Inc. | 374.88M | -2.90% | 332,923 | 14.56M |
| 247 | CADL | Candel Therapeutics, Inc. | 374.29M | 4.07% | 560,940 | - |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 373.48M | -1.00% | 34,776 | 66.98M |
| 249 | KYTX | Kyverna Therapeutics, Inc. | 358.69M | -4.10% | 421,380 | - |
| 250 | DMAC | DiaMedica Therapeutics Inc. | 355.43M | -2.78% | 79,482 | - |
| 251 | OVID | Ovid Therapeutics Inc. | 354.08M | 16.74% | 4,684,186 | 7.25M |
| 252 | LENZ | LENZ Therapeutics, Inc. | 353.58M | -1.65% | 221,797 | 17.50M |
| 253 | XOMA | XOMA Royalty Corporation | 347.65M | 1.53% | 42,126 | 52.15M |
| 254 | NERV | Minerva Neurosciences, Inc. | 347.06M | -0.62% | 180,352 | - |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 345.67M | -3.59% | 47,809 | - |
| 256 | PEPG | PepGen Inc. | 328.30M | -0.42% | 155,532 | - |
| 257 | IRD | Opus Genetics, Inc. | 325.15M | -0.22% | 344,942 | 14.20M |
| 258 | IMRX | Immuneering Corporation | 316.15M | 0.62% | 335,594 | - |
| 259 | IMMX | Immix Biopharma, Inc. | 313.79M | -3.46% | 333,143 | - |
| 260 | CLYM | Climb Bio, Inc. | 312.40M | -6.30% | 243,143 | - |
| 261 | PBYI | Puma Biotechnology, Inc. | 311.87M | -0.33% | 89,635 | 228.37M |
| 262 | BCYC | Bicycle Therapeutics plc | 304.62M | -3.96% | 578,055 | 72.59M |
| 263 | CBIO | Crescent Biopharma, Inc. | 303.12M | 3.58% | 29,914 | 10.84M |
| 264 | ARMP | Armata Pharmaceuticals, Inc. | 302.63M | 0.48% | 16,610 | 5.05M |
| 265 | NBP | NovaBridge Biosciences | 301.49M | -2.79% | 180,140 | - |
| 266 | FHTX | Foghorn Therapeutics Inc. | 300.55M | 4.70% | 94,153 | 30.91M |
| 267 | ACIU | AC Immune SA | 300.23M | - | 124,246 | 4.51M |
| 268 | NGNE | Neurogene Inc. | 295.55M | -0.57% | 72,521 | 925.00K |
| 269 | CABA | Cabaletta Bio, Inc. | 295.53M | 0.99% | 843,793 | - |
| 270 | PALI | Palisade Bio, Inc. | 295.03M | -0.50% | 1,332,453 | - |
| 271 | SLN | Silence Therapeutics plc | 293.56M | -2.59% | 112,751 | 559.00K |
| 272 | ALXO | ALX Oncology Holdings Inc. | 292.17M | 1.37% | 301,955 | - |
| 273 | FBRX | Forte Biosciences, Inc. | 290.25M | -5.85% | 73,493 | - |
| 274 | TARA | Protara Therapeutics, Inc. | 288.81M | 0.75% | 206,171 | - |
| 275 | PROK | ProKidney Corp. | 279.63M | 1.03% | 249,902 | 893.00K |
| 276 | OBIO | Orchestra BioMed Holdings, Inc. | 269.78M | -0.65% | 88,821 | 33.48M |
| 277 | CNTX | Context Therapeutics Inc. | 267.83M | -2.51% | 109,291 | - |
| 278 | CCCC | C4 Therapeutics, Inc. | 266.39M | 4.60% | 1,641,330 | 35.95M |
| 279 | OABI | OmniAb, Inc. | 262.06M | -1.63% | 151,300 | 18.67M |
| 280 | ABEO | Abeona Therapeutics Inc. | 259.86M | 0.33% | 474,025 | 5.82M |
| 281 | TENX | Tenax Therapeutics, Inc. | 257.96M | 0.60% | 111,730 | - |
| 282 | CAMP | Camp4 Therapeutics Corporation | 256.22M | -4.36% | 52,195 | 3.50M |
| 283 | PLYX | Polaryx Therapeutics, Inc. | 255.18M | -4.60% | 137,969 | - |
| 284 | AVTX | Avalo Therapeutics, Inc. | 251.28M | -2.55% | 173,177 | 192.00K |
| 285 | CLLS | Cellectis S.A. | 247.73M | -4.89% | 36,656 | 82.55M |
| 286 | HELP | Cybin Inc. | 245.18M | 1.87% | 192,629 | - |
| 287 | CHRS | Coherus Oncology, Inc. | 236.08M | -2.17% | 414,527 | 42.17M |
| 288 | EDIT | Editas Medicine, Inc. | 235.87M | 2.55% | 403,700 | 40.52M |
| 289 | RZLT | Rezolute, Inc. | 235.42M | -0.40% | 380,136 | - |
| 290 | ELDN | Eledon Pharmaceuticals, Inc. | 228.31M | 5.61% | 1,200,797 | - |
| 291 | ALEC | Alector, Inc. | 226.80M | -0.24% | 182,067 | 21.05M |
| 292 | VYGR | Voyager Therapeutics, Inc. | 225.29M | 1.07% | 199,763 | 40.37M |
| 293 | TNXP | Tonix Pharmaceuticals Holding Corp. | 224.54M | 6.21% | 368,055 | 13.11M |
| 294 | SRZN | Surrozen, Inc. | 223.29M | -2.18% | 33,996 | 3.60M |
| 295 | MDWD | MediWound Ltd. | 220.51M | 1.24% | 28,064 | 16.96M |
| 296 | ACHV | Achieve Life Sciences, Inc. | 218.79M | 0.49% | 91,642 | - |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 217.32M | -4.54% | 5,574 | 19.39M |
| 298 | KROS | Keros Therapeutics, Inc. | 216.30M | -1.35% | 243,258 | 244.06M |
| 299 | NVCT | Nuvectis Pharma, Inc. | 215.64M | 0.74% | 22,954 | - |
| 300 | ELTX | Elicio Therapeutics, Inc. | 214.31M | -2.75% | 26,713 | - |
| 301 | FENC | Fennec Pharmaceuticals Inc. | 213.13M | -0.92% | 45,382 | 38.79M |
| 302 | CGEN | Compugen Ltd. | 203.29M | 1.90% | 72,256 | 72.76M |
| 303 | SABS | SAB Biotherapeutics, Inc. | 192.59M | - | 143,752 | 114.70K |
| 304 | ARCT | Arcturus Therapeutics Holdings Inc. | 192.42M | 0.74% | 227,097 | 82.03M |
| 305 | PRLD | Prelude Therapeutics Incorporated | 188.69M | -6.11% | 114,631 | 12.14M |
| 306 | ZNTL | Zentalis Pharmaceuticals, Inc. | 187.49M | 1.37% | 77,347 | 26.87M |
| 307 | CRBU | Caribou Biosciences, Inc. | 184.09M | -3.30% | 418,211 | 11.16M |
| 308 | MGNX | MacroGenics, Inc. | 183.36M | -0.52% | 230,127 | 149.50M |
| 309 | GALT | Galectin Therapeutics Inc. | 179.23M | -0.71% | 43,060 | - |
| 310 | ADAG | Adagene Inc. | 178.86M | 2.85% | 31,458 | 103.20K |
| 311 | CBUS | Cibus, Inc. | 178.53M | -3.01% | 228,900 | 3.79M |
| 312 | MOLN | Molecular Partners AG | 176.68M | 0.70% | 1,349 | 856.30K |
| 313 | STRO | Sutro Biopharma, Inc. | 176.40M | -1.89% | 44,338 | 105.65M |
| 314 | TNYA | Tenaya Therapeutics, Inc. | 175.70M | 0.75% | 985,191 | - |
| 315 | PLX | Protalix BioTherapeutics, Inc. | 175.32M | -2.24% | 413,246 | 52.74M |
| 316 | RNAC | Cartesian Therapeutics, Inc. | 174.69M | 0.30% | 40,169 | 2.80M |
| 317 | NTHI | NeOnc Technologies Holdings, Inc. | 174.50M | -3.87% | 21,837 | 59.99K |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 172.33M | -1.04% | 190,287 | - |
| 319 | ABOS | Acumen Pharmaceuticals, Inc. | 168.39M | -4.79% | 185,512 | - |
| 320 | WHWK | Whitehawk Therapeutics, Inc. | 167.55M | -1.11% | 36,693 | 7.15M |
| 321 | EVAX | Evaxion A/S | 164.72M | -1.25% | 14,047 | 7.53M |
| 322 | PRQR | ProQR Therapeutics N.V. | 164.36M | -1.89% | 58,837 | 19.19M |
| 323 | DTIL | Precision BioSciences, Inc. | 163.57M | -1.56% | 122,199 | 34.26M |
| 324 | KPTI | Karyopharm Therapeutics Inc. | 163.26M | 15.14% | 832,247 | 146.07M |
| 325 | SGMT | Sagimet Biosciences Inc. | 162.93M | 3.52% | 197,347 | - |
| 326 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 158.92M | 0.22% | 23,494 | - |
| 327 | PMN | ProMIS Neurosciences, Inc. | 158.55M | -2.91% | 5,255 | - |
| 328 | KRRO | Korro Bio, Inc. | 156.70M | -1.76% | 67,810 | 6.39M |
| 329 | CNTB | Connect Biopharma Holdings Limited | 155.69M | -2.96% | 31,037 | 762.00K |
| 330 | KLRS | Kalaris Therapeutics, Inc. | 153.62M | -1.62% | 15,777 | - |
| 331 | NKTX | Nkarta, Inc. | 153.42M | -0.46% | 143,238 | - |
| 332 | VXRT | Vaxart, Inc. | 151.30M | -2.97% | 198,983 | 237.26M |
| 333 | HRTX | Heron Therapeutics, Inc. | 150.70M | -2.20% | 447,063 | 154.90M |
| 334 | ANTX | AN2 Therapeutics, Inc. | 149.52M | 6.39% | 127,756 | - |
| 335 | HUMA | Humacyte, Inc. | 148.88M | -6.92% | 24,031,377 | 1.57M |
| 336 | IMUX | Immunic, Inc. | 148.73M | -1.72% | 520,674 | - |
| 337 | UNCY | Unicycive Therapeutics, Inc. | 148.08M | 1.17% | 258,909 | - |
| 338 | VTVT | vTv Therapeutics Inc. | 145.93M | 3.00% | 3,720 | 17.00K |
| 339 | AGEN | Agenus Inc. | 143.61M | -1.84% | 138,162 | 114.20M |
| 340 | CDXS | Codexis, Inc. | 143.57M | -5.39% | 571,182 | 70.39M |
| 341 | MIST | Milestone Pharmaceuticals Inc. | 143.23M | -17.06% | 3,658,630 | 1.55M |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 140.50M | -2.22% | 16,798 | 2.00M |
| 343 | VOR | Vor Biopharma Inc. | 138.15M | 0.76% | 463,618 | - |
| 344 | IKT | Inhibikase Therapeutics, Inc. | 137.19M | -0.27% | 519,323 | 1.00 |
| 345 | SPRO | Spero Therapeutics, Inc. | 136.34M | -2.02% | 89,156 | 40.55M |
| 346 | EQ | Equillium, Inc. | 134.57M | 3.27% | 314,074 | 4.39M |
| 347 | ARTV | Artiva Biotherapeutics, Inc. | 132.85M | -2.63% | 37,106 | 251.00K |
| 348 | MENS | Jyong Biotech Ltd. | 129.91M | -2.23% | 150,133 | - |
| 349 | FATE | Fate Therapeutics, Inc. | 128.47M | 2.31% | 776,343 | 6.65M |
| 350 | CRDF | Cardiff Oncology, Inc. | 126.13M | 1.37% | 185,274 | 593.00K |
| 351 | BDTX | Black Diamond Therapeutics, Inc. | 124.03M | 0.70% | 225,643 | 70.00M |
| 352 | ACOG | Alpha Cognition Inc. | 123.93M | -2.40% | 2,755 | 7.43M |
| 353 | ALDX | Aldeyra Therapeutics, Inc. | 121.57M | 10.38% | 5,735,509 | - |
| 354 | IPHA | Innate Pharma S.A. | 114.71M | -3.62% | 27,730 | 14.84M |
| 355 | SGMO | Sangamo Therapeutics, Inc. | 112.32M | -2.11% | 2,916,502 | 32.88M |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 111.24M | -2.42% | 265,901 | 65.34K |
| 357 | RANI | Rani Therapeutics Holdings, Inc. | 108.76M | -3.04% | 402,137 | 1.20M |
| 358 | GNLX | Genelux Corporation | 108.43M | -4.72% | 114,104 | 8.00K |
| 359 | ONCY | Oncolytics Biotech Inc. | 104.38M | -0.91% | 168,799 | - |
| 360 | DWTX | Dogwood Therapeutics, Inc. | 102.88M | 13.44% | 48,977 | - |
| 361 | TTRX | Turn Therapeutics Inc. | 100.41M | -0.58% | 6,527 | - |
| 362 | QTTB | Q32 Bio Inc. | 100.21M | 2.70% | 207,319 | 53.74M |
| 363 | VRCA | Verrica Pharmaceuticals Inc. | 99.89M | 0.26% | 88,881 | 35.58M |
| 364 | COYA | Coya Therapeutics, Inc. | 98.75M | -1.41% | 37,912 | 7.95M |
| 365 | CGTX | Cognition Therapeutics, Inc. | 97.54M | 2.31% | 293,734 | - |
| 366 | HURA | TuHURA Biosciences, Inc. | 96.88M | 5.59% | 258,335 | - |
| 367 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 96.40M | -1.01% | 1,454,375 | - |
| 368 | GOSS | Gossamer Bio, Inc. | 96.01M | -9.49% | 6,508,183 | 48.47M |
| 369 | SEER | Seer, Inc. | 95.92M | -1.45% | 83,097 | 16.58M |
| 370 | FBIO | Fortress Biotech, Inc. | 95.29M | -2.23% | 94,267 | 62.30M |
| 371 | PYXS | Pyxis Oncology, Inc. | 94.64M | -1.30% | 66,874 | 2.82M |
| 372 | AARD | Aardvark Therapeutics, Inc. | 93.52M | -12.35% | 233,131 | - |
| 373 | ANIX | Anixa Biosciences, Inc. | 90.86M | -2.17% | 33,346 | - |
| 374 | NRXS | NeurAxis, Inc. | 86.93M | 8.52% | 318,800 | 3.57M |
| 375 | CING | Cingulate Inc. | 85.35M | -2.26% | 687,099 | - |
| 376 | KZIA | Kazia Therapeutics Limited | 84.99M | -1.39% | 21,374 | 1.35M |
| 377 | CSBR | Champions Oncology, Inc. | 84.87M | -1.43% | 1,402 | 57.95M |
| 378 | VANI | Vivani Medical, Inc. | 84.62M | 0.87% | 149,699 | - |
| 379 | MCRB | Seres Therapeutics, Inc. | 84.26M | -3.19% | 32,960 | 789.00K |
| 380 | SPRB | Spruce Biosciences, Inc. | 83.69M | 3.30% | 14,051 | 697.00K |
| 381 | ATYR | aTyr Pharma, Inc. | 82.08M | 1.15% | 317,645 | 190.00K |
| 382 | PLRX | Pliant Therapeutics, Inc. | 81.73M | -0.75% | 37,274 | - |
| 383 | BMEA | Biomea Fusion, Inc. | 80.96M | 5.05% | 465,018 | - |
| 384 | PMVP | PMV Pharmaceuticals, Inc. | 80.26M | 0.33% | 55,349 | - |
| 385 | PYPD | PolyPid Ltd. | 77.56M | -2.51% | 14,626 | - |
| 386 | ANVS | Annovis Bio, Inc. | 75.99M | 0.37% | 298,805 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 72.80M | -2.03% | 3,084 | 16.80M |
| 388 | MNOV | MediciNova, Inc. | 71.76M | 4.89% | 62,555 | 409.66K |
| 389 | XBIT | XBiotech Inc. | 71.65M | - | 41,812 | - |
| 390 | IBIO | iBio, Inc. | 71.33M | -1.67% | 205,779 | 300.00K |
| 391 | GRCE | Grace Therapeutics, Inc. | 70.56M | 4.11% | 320,079 | - |
| 392 | GANX | Gain Therapeutics, Inc. | 70.21M | 2.37% | 409,857 | - |
| 393 | IFRX | InflaRx N.V. | 69.96M | 6.39% | 440,971 | 34.44K |
| 394 | COEP | Coeptis Therapeutics Holdings, Inc. | 68.83M | -2.12% | 20,371 | 1.36M |
| 395 | ACET | Adicet Bio, Inc. | 67.27M | -0.85% | 30,923 | - |
| 396 | ACRV | Acrivon Therapeutics, Inc. | 66.06M | 0.29% | 168,506 | - |
| 397 | BYSI | BeyondSpring Inc. | 64.54M | 2.58% | 4,605 | 1.88M |
| 398 | ATHE | Alterity Therapeutics Limited | 63.04M | 0.82% | 2,862 | 4.43M |
| 399 | EXOZ | eXoZymes, Inc. | 62.67M | 1.24% | 2,613 | -700.00 |
| 400 | EDSA | Edesa Biotech, Inc. | 61.78M | 2.35% | 2,065,449 | - |
| 401 | OKUR | OnKure Therapeutics, Inc. | 61.53M | 2.74% | 265,097 | - |
| 402 | IMA | ImageneBio, Inc. | 60.62M | - | 5,015 | 800.00K |
| 403 | GUTS | Fractyl Health, Inc. | 60.30M | 0.78% | 374,980 | 3.00K |
| 404 | TCRX | TScan Therapeutics, Inc. | 59.75M | 0.96% | 252,751 | 10.33M |
| 405 | HYFT | MindWalk Holdings Corp. | 59.35M | -2.05% | 72,710 | 20.70M |
| 406 | TIL | Instil Bio, Inc. | 57.78M | 0.47% | 8,630 | - |
| 407 | MREO | Mereo BioPharma Group plc | 56.93M | -1.11% | 955,413 | 500.00K |
| 408 | ACTU | Actuate Therapeutics, Inc. | 56.13M | -3.40% | 45,137 | - |
| 409 | IMMP | Immutep Limited | 56.03M | -7.49% | 923,578 | 5.28M |
| 410 | ICCC | ImmuCell Corporation | 55.50M | -0.24% | 401 | 27.64M |
| 411 | MGX | Metagenomi Therapeutics, Inc. | 54.55M | -1.36% | 56,858 | 25.21M |
| 412 | OSTX | OS Therapies Incorporated | 53.53M | 1.33% | 173,109 | - |
| 413 | RADX | Radiopharm Theranostics Limited | 53.46M | -4.13% | 12,054 | 10.86M |
| 414 | MAIA | MAIA Biotechnology, Inc. | 53.33M | -4.00% | 267,830 | - |
| 415 | LPCN | Lipocine Inc. | 53.07M | -0.55% | 27,713 | 1.98M |
| 416 | NRXP | NRx Pharmaceuticals, Inc. | 52.26M | 1.09% | 227,797 | 242.00K |
| 417 | ATOS | Atossa Therapeutics, Inc. | 50.46M | 14.23% | 80,119 | - |
| 418 | ENTX | Entera Bio Ltd. | 50.44M | -7.56% | 88,611 | 124.00K |
| 419 | KZR | Kezar Life Sciences, Inc. | 49.72M | 1.42% | 6,552 | - |
| 420 | DCOY | Decoy Therapeutics Inc. | 49.45M | -3.00% | 8,643 | - |
| 421 | RLYB | Rallybio Corporation | 48.48M | 0.83% | 53,254 | 858.00K |
| 422 | IBO | Impact BioMedical Inc. | 46.09M | -7.67% | 128,594 | 32.00K |
| 423 | LSTA | Lisata Therapeutics, Inc. | 45.25M | -0.20% | 46,865 | 170.00K |
| 424 | TELO | Telomir Pharmaceuticals, Inc. | 45.04M | -0.76% | 29,891 | - |
| 425 | ALGS | Aligos Therapeutics, Inc. | 44.92M | -1.09% | 20,420 | 2.19M |
| 426 | ESLA | Estrella Immunopharma, Inc. | 44.56M | 7.27% | 22,453 | - |
| 427 | INKT | MiNK Therapeutics, Inc. | 44.45M | -2.77% | 12,793 | - |
| 428 | NTRB | Nutriband Inc. | 43.21M | -9.11% | 20,259 | 2.28M |
| 429 | LITS | Lite Strategy, Inc. | 43.09M | 1.28% | 72,851 | - |
| 430 | PSTV | Plus Therapeutics, Inc. | 42.61M | 3.03% | 1,490,160 | 5.21M |
| 431 | SNSE | Sensei Biotherapeutics, Inc. | 42.27M | 9.66% | 64,400 | - |
| 432 | ATRA | Atara Biotherapeutics, Inc. | 41.54M | -0.78% | 28,065 | 120.77M |
| 433 | LONA | LeonaBio, Inc. | 41.23M | 5.29% | 42,158 | - |
| 434 | GOVX | GeoVax Labs, Inc. | 41.18M | -4.20% | 101,700 | 3.35M |
| 435 | APLM | Apollomics, Inc. | 41.01M | -0.99% | 895 | 6.93M |
| 436 | PTN | Palatin Technologies, Inc. | 39.45M | 12.99% | 18,841 | 8.96M |
| 437 | CMMB | Chemomab Therapeutics Ltd. | 39.11M | -2.07% | 5,577 | - |
| 438 | CRVO | CervoMed Inc. | 38.28M | -2.25% | 7,726 | 4.01M |
| 439 | HOWL | Werewolf Therapeutics, Inc. | 37.87M | -3.70% | 98,505 | 1.14M |
| 440 | RNXT | RenovoRx, Inc. | 37.38M | 0.99% | 154,759 | 928.00K |
| 441 | VERU | Veru Inc. | 36.11M | -1.75% | 35,175 | 16.89M |
| 442 | NXTC | NextCure, Inc. | 35.76M | -0.35% | 7,766 | - |
| 443 | CELU | Celularity Inc. | 35.76M | -2.36% | 46,612 | 40.58M |
| 444 | JSPR | Jasper Therapeutics, Inc. | 34.98M | 2.46% | 80,116 | - |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 33.85M | -0.46% | 47,235 | 90.00K |
| 446 | TVRD | Tvardi Therapeutics, Inc. | 33.77M | -2.17% | 17,304 | - |
| 447 | BCTX | BriaCell Therapeutics Corp. | 32.73M | -3.98% | 95,826 | - |
| 448 | RNTX | Rein Therapeutics Inc. | 32.51M | -4.88% | 64,514 | - |
| 449 | NBY | NovaBay Pharmaceuticals, Inc. | 32.48M | - | 52,935 | 10.30M |
| 450 | INMB | INmune Bio Inc. | 32.43M | - | 2,036,541 | 50.00K |
| 451 | DYAI | Dyadic International, Inc. | 31.84M | 10.22% | 72,272 | 3.34M |
| 452 | PLUR | Pluri Inc. | 31.16M | -0.96% | 3,782 | 1.34M |
| 453 | CVM | CEL-SCI Corporation | 31.13M | 0.55% | 3,983 | - |
| 454 | ABVC | ABVC BioPharma, Inc. | 31.04M | -5.43% | 34,113 | 797.92K |
| 455 | TPST | Tempest Therapeutics, Inc. | 30.20M | 3.70% | 45,014 | - |
| 456 | PDSB | PDS Biotechnology Corporation | 29.66M | -3.12% | 113,869 | - |
| 457 | XCUR | Exicure, Inc. | 29.64M | -2.11% | 42,232 | 500.00K |
| 458 | TLSA | Tiziana Life Sciences Ltd | 29.47M | -1.59% | 31,589 | - |
| 459 | KYNB | Kyntra Bio, Inc. | 29.44M | -0.35% | 16,727 | 6.44M |
| 460 | XLO | Xilio Therapeutics, Inc. | 28.80M | 5.35% | 20,488 | 31.80M |
| 461 | OTLK | Outlook Therapeutics, Inc. | 28.25M | 1.16% | 294,819 | 205.70K |
| 462 | HYPD | Hyperion DeFi, Inc. | 27.77M | -5.77% | 135,869 | 345.32K |
| 463 | BOLD | Boundless Bio, Inc. | 26.78M | 3.91% | 38,884 | - |
| 464 | CUE | Cue Biopharma, Inc. | 26.21M | 1.59% | 408,872 | 27.47M |
| 465 | NRSN | NeuroSense Therapeutics Ltd. | 26.05M | -1.09% | 31,811 | - |
| 466 | BRNS | Barinthus Biotherapeutics plc | 25.73M | - | 4,559 | 14.97M |
| 467 | SER | Serina Therapeutics, Inc. | 25.70M | -2.82% | 11,821,239 | 116.00K |
| 468 | ENLV | Enlivex Ltd. | 25.55M | -0.84% | 83,245 | - |
| 469 | IGC | IGC Pharma, Inc. | 25.23M | -0.11% | 279,805 | 1.11M |
| 470 | VTGN | Vistagen Therapeutics, Inc. | 24.69M | -2.97% | 76,416 | 789.00K |
| 471 | LTRN | Lantern Pharma Inc. | 24.16M | - | 6,759 | - |
| 472 | PASG | Passage Bio, Inc. | 24.12M | 1.90% | 59,720 | - |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 23.83M | 0.45% | 16,210 | 14.99M |
| 474 | LGVN | Longeveron Inc. | 23.38M | -9.46% | 1,254,331 | 1.20M |
| 475 | SNTI | Senti Biosciences, Inc. | 22.89M | -3.35% | 82,848 | - |
| 476 | MRKR | Marker Therapeutics, Inc. | 22.51M | 2.27% | 45,529 | 3.55M |
| 477 | NNVC | NanoViricides, Inc. | 22.03M | -2.86% | 129,527 | - |
| 478 | SKYE | Skye Bioscience, Inc. | 21.62M | -1.13% | 162,054 | - |
| 479 | VYNE | VYNE Therapeutics Inc. | 20.35M | -1.38% | 130,539 | 570.00K |
| 480 | DARE | Daré Bioscience, Inc. | 18.86M | 1.54% | 69,683 | -57.13K |
| 481 | LEXX | Lexaria Bioscience Corp. | 18.64M | 3.32% | 58,958 | 522.00K |
| 482 | KTTA | Pasithea Therapeutics Corp. | 18.02M | -0.19% | 90,940 | - |
| 483 | CTXR | Citius Pharmaceuticals, Inc. | 17.46M | -3.98% | 73,344 | 3.94M |
| 484 | INAB | IN8bio, Inc. | 17.43M | 2.91% | 49,279 | - |
| 485 | ALLR | Allarity Therapeutics, Inc. | 17.08M | -1.82% | 58,914 | - |
| 486 | FBLG | FibroBiologics, Inc. | 17.06M | -1.37% | 428,619 | - |
| 487 | TRAW | Traws Pharma, Inc. | 16.94M | -2.75% | 26,033 | 2.85M |
| 488 | ACXP | Acurx Pharmaceuticals, Inc. | 16.93M | -10.56% | 758,834 | - |
| 489 | ARTL | Artelo Biosciences, Inc. | 16.83M | 10.61% | 11,480,375 | - |
| 490 | LIXT | Lixte Biotechnology Holdings, Inc. | 16.14M | -2.75% | 17,699 | - |
| 491 | AEON | AEON Biopharma, Inc. | 15.73M | 0.88% | 14,349 | - |
| 492 | INTS | Intensity Therapeutics, Inc. | 15.72M | -1.97% | 21,154 | - |
| 493 | COCP | Cocrystal Pharma, Inc. | 15.16M | 0.92% | 8,949 | - |
| 494 | HOTH | Hoth Therapeutics, Inc. | 14.46M | 0.95% | 72,411 | - |
| 495 | GTBP | GT Biopharma, Inc. | 14.04M | 4.61% | 542,105 | - |
| 496 | CVKD | Cadrenal Therapeutics, Inc. | 14.03M | -3.01% | 17,941 | - |
| 497 | PHIO | Phio Pharmaceuticals Corp. | 13.77M | 0.42% | 114,662 | - |
| 498 | PLRZ | Polyrizon Ltd. | 13.28M | 0.37% | 3,627 | - |
| 499 | CLRB | Cellectar Biosciences, Inc. | 13.21M | -2.04% | 4,917 | - |
| 500 | IOBT | IO Biotech, Inc. | 13.15M | -3.84% | 591,598 | - |
| 501 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.01M | -2.54% | 7,650 | - |
| 502 | BCDA | BioCardia, Inc. | 12.74M | - | 7,328 | 3.00K |
| 503 | SNGX | Soligenix, Inc. | 12.20M | -0.82% | 19,488 | 2.34K |
| 504 | JUNS | Jupiter Neurosciences, Inc. | 11.89M | -8.40% | 271,926 | - |
| 505 | GNTA | Genenta Science S.p.A. | 11.84M | -1.09% | 68,598 | - |
| 506 | KAPA | Kairos Pharma, Ltd. | 11.75M | -8.26% | 20,836 | - |
| 507 | GDTC | CytoMed Therapeutics Limited | 11.54M | -4.76% | 5,808 | 573.19K |
| 508 | LNAI | Lunai Bioworks Inc. | 11.36M | 21.95% | 73,002,351 | - |
| 509 | MBRX | Moleculin Biotech, Inc. | 11.21M | 1.94% | 42,118 | - |
| 510 | BLRX | BioLineRx Ltd. | 11.19M | -3.12% | 1,234 | 12.74M |
| 511 | OSRH | OSR Holdings, Inc. | 10.90M | -4.29% | 100,494 | -90.52K |
| 512 | CALC | CalciMedica, Inc. | 10.89M | -6.17% | 86,992 | - |
| 513 | NCEL | NewcelX Ltd. | 10.80M | -3.27% | 10,148 | - |
| 514 | BIVI | BioVie Inc. | 10.37M | -5.82% | 17,003 | - |
| 515 | BCAB | BioAtla, Inc. | 9.76M | 6.21% | 187,069 | 11.00M |
| 516 | CRIS | Curis, Inc. | 9.71M | -0.73% | 136,465 | 9.44M |
| 517 | IMNN | Imunon, Inc. | 9.30M | 2.71% | 10,802 | - |
| 518 | BOLT | Bolt Biotherapeutics, Inc. | 8.97M | 2.77% | 9,684 | 7.70M |
| 519 | QNTM | Quantum BioPharma Ltd. | 8.89M | -2.97% | 39,271 | - |
| 520 | PULM | Pulmatrix, Inc. | 8.77M | 11.63% | 56,431 | 3.00K |
| 521 | ITRM | Iterum Therapeutics plc | 8.65M | -3.93% | 185,517 | 390.00K |
| 522 | TOVX | Theriva Biologics, Inc. | 8.63M | 1.35% | 1,047,307 | - |
| 523 | APRE | Aprea Therapeutics, Inc. | 8.55M | -2.16% | 30,184 | 488.24K |
| 524 | RNAZ | TransCode Therapeutics, Inc. | 8.29M | -2.90% | 4,593 | - |
| 525 | ERNA | Ernexa Therapeutics Inc. | 8.25M | 4.81% | 932,739 | 1,000.00 |
| 526 | ICU | SeaStar Medical Holding Corporation | 7.86M | -3.96% | 66,261 | 881.00K |
| 527 | PHGE | BiomX Inc. | 7.62M | -4.02% | 17,843 | - |
| 528 | PMCB | PharmaCyte Biotech, Inc. | 7.53M | -0.14% | 27,333 | - |
| 529 | CLGN | CollPlant Biotechnologies Ltd. | 7.46M | -4.28% | 2,999 | 2.48M |
| 530 | KPRX | Kiora Pharmaceuticals, Inc. | 7.43M | -0.49% | 386 | 20.00K |
| 531 | SPRC | SciSparc Ltd. | 7.40M | -2.15% | 3,591 | 1.31M |
| 532 | TCRT | Alaunos Therapeutics, Inc. | 7.30M | -1.13% | 11,240 | 6.00K |
| 533 | EVGN | Evogene Ltd. | 7.28M | -1.39% | 16,763 | 3.85M |
| 534 | NCNA | NuCana plc | 7.12M | - | 31,055 | - |
| 535 | XBIO | Xenetic Biosciences, Inc. | 7.08M | 1.98% | 6,807 | 2.98M |
| 536 | ADXN | Addex Therapeutics Ltd | 6.91M | -2.92% | 726 | 198.82K |
| 537 | ALZN | Alzamend Neuro, Inc. | 6.84M | -4.89% | 56,669 | - |
| 538 | CDIO | Cardio Diagnostics Holdings, Inc. | 6.81M | -6.50% | 217,701 | 14.83K |
| 539 | GRDX | GridAI Technologies Corp. | 6.72M | -4.31% | 53,535 | - |
| 540 | PCSA | Processa Pharmaceuticals, Inc. | 6.30M | 1.72% | 16,852 | - |
| 541 | CYCN | Cyclerion Therapeutics, Inc. | 5.93M | - | 9,019 | 2.86M |
| 542 | MLEC | Moolec Science SA | 5.87M | -12.55% | 11,518 | 7.83M |
| 543 | APM | Aptorum Group Limited | 5.85M | -1.62% | 70,540 | - |
| 544 | IMRN | Immuron Limited | 5.81M | 0.39% | 5,712 | 4.99M |
| 545 | LIMN | Liminatus Pharma, Inc. | 5.60M | 3.14% | 1,040,624 | - |
| 546 | PBM | Psyence Biomedical Ltd. | 5.49M | 1.91% | 3,354 | - |
| 547 | MBIO | Mustang Bio, Inc. | 5.49M | -4.11% | 13,815 | - |
| 548 | XTLB | XTL Biopharmaceuticals Ltd. | 5.29M | 1.52% | 10,055 | 968.00K |
| 549 | QNCX | Quince Therapeutics, Inc. | 5.07M | 3.88% | 7,988,238 | - |
| 550 | AKTX | Akari Therapeutics, Plc | 4.98M | -4.26% | 131,560 | - |
| 551 | CELZ | Creative Medical Technology Holdings, Inc. | 4.80M | -1.06% | 7,453 | 6.00K |
| 552 | REVB | Revelation Biosciences, Inc. | 4.50M | 0.83% | 7,327 | - |
| 553 | GNPX | Genprex, Inc. | 4.48M | 0.52% | 126,111 | - |
| 554 | VIVS | VivoSim Labs, Inc. | 4.43M | -4.49% | 10,726 | 142.00K |
| 555 | BGMS | Bio Green Med Solution, Inc. | 4.42M | -1.95% | 8,824 | 81.00K |
| 556 | BDRX | Biodexa Pharmaceuticals Plc | 4.37M | 2.74% | 54,342 | 104.90K |
| 557 | AZTR | Azitra, Inc. | 4.35M | 52.41% | 447,063,339 | 7.50K |
| 558 | SILO | Silo Pharma, Inc. | 4.33M | -0.31% | 31,892 | 72.10K |
| 559 | APVO | Aptevo Therapeutics Inc. | 4.31M | 2.22% | 18,233 | - |
| 560 | SLXN | Silexion Therapeutics Corp | 4.23M | -11.73% | 53,235 | - |
| 561 | INDP | Indaptus Therapeutics, Inc. | 3.91M | -0.85% | 33,510 | - |
| 562 | MTNB | Matinas BioPharma Holdings, Inc. | 3.79M | 0.29% | 2,128 | - |
| 563 | ASBP | Aspire Biopharma Holdings, Inc. | 3.77M | 13.99% | 197,580 | 1.94K |
| 564 | GRI | GRI Bio, Inc. | 3.70M | -1.92% | 15,109 | - |
| 565 | PPBT | Purple Biotech Ltd | 3.70M | 5.05% | 7,548 | - |
| 566 | XRTX | XORTX Therapeutics Inc. | 3.25M | -0.18% | 10,052 | - |
| 567 | GLMD | Galmed Pharmaceuticals Ltd. | 3.19M | -0.33% | 5,791 | - |
| 568 | OGEN | Oragenics, Inc. | 3.02M | -7.38% | 71,151 | - |
| 569 | ADIL | Adial Pharmaceuticals, Inc. | 2.86M | 6.95% | 124,436 | - |
| 570 | ENVB | Enveric Biosciences, Inc. | 2.78M | 2.04% | 7,048 | - |
| 571 | BRTX | BioRestorative Therapies, Inc. | 2.46M | 8.39% | 3,780,509 | 383.40K |
| 572 | HCWB | HCW Biologics Inc. | 2.42M | -2.14% | 688,268 | 422.03K |
| 573 | SCNI | Scinai Immunotherapeutics Ltd. | 2.23M | 0.35% | 6,798 | 1.15M |
| 574 | CLDI | Calidi Biotherapeutics, Inc. | 2.09M | -2.70% | 78,768 | - |
| 575 | BBLG | Bone Biologics Corporation | 2.08M | - | 3,347 | - |
| 576 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.04M | -0.26% | 30,540 | 1.36M |
| 577 | DRMA | Dermata Therapeutics, Inc. | 2.00M | 40.50% | 30,010,893 | - |
| 578 | KALA | KALA BIO, Inc. | 1.91M | -5.57% | 1,823,913 | - |
| 579 | ENSC | Ensysce Biosciences, Inc. | 1.90M | -6.67% | 298,630 | 4.49M |
| 580 | PPCB | Propanc Biopharma, Inc. | 1.79M | 1.20% | 579,030 | - |
| 581 | ONCO | Onconetix, Inc. | 1.78M | 3.06% | 87,473 | 815.37K |
| 582 | JAGX | Jaguar Health, Inc. | 1.56M | -0.28% | 196,419 | 11.79M |
| 583 | CNSP | CNS Pharmaceuticals, Inc. | 1.36M | 0.92% | 4,297 | - |
| 584 | CMND | Clearmind Medicine Inc. | 974.37K | -0.85% | 31,574 | - |
| 585 | OKYO | OKYO Pharma Limited | 961.44K | 3.09% | 27,229 | - |
| 586 | VRAX | Virax Biolabs Group Limited | 793.28K | 0.61% | 21,424 | 2.99K |
| 587 | CDT | CDT Equity Inc. | 749.53K | -4.56% | 20,541 | - |
| 588 | ADTX | Aditxt, Inc. | 693.71K | -0.80% | 51,563 | 5.95K |
| 589 | MTVA | MetaVia Inc. | 305.82K | -1.18% | 41,361 | - |
| 590 | ELAB | PMGC Holdings Inc. | 303.91K | -4.49% | 21,466 | 285.95K |
| 591 | CANF | Can-Fite BioPharma Ltd. | 18.15K | -4.20% | 33,965 | 560.00K |